CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
Baseline Polymorphisms and Emergence of Drug Resistance in the NS3/4A Protease of Hepatitis C Virus Genotype 1 following Treatment with Faldaprevir and Pegylated Interferon Alpha 2a/Ribavirin in Phase 2 and Phase 3 Studies
Author
A.-M. Quinson
American Association for the Study of Liver Disease Infectious Diseases Society of America HCV Panel
+16Â more
European Association for Study of Liver
G. Kukolj
HCV Phenotype Working Group HCV Drug Development Advisory Group
HCV RESPOND-2 Investigators
J. O. Stern
J. Scherer
Janssen Products LP
K. L. Berger
M. Ranga
Merck Sharp & Dohme Corp
N. Sha
STARTVerso1 and STARTVerso2 Study Groups
STARTVerso1 Study Group
STARTVerso4 Study Group
U.S. Food and Drug Administration Center for Drug Evaluation Research
Vertex Pharmaceuticals Incorporated
Publication venue
'American Society for Microbiology'
Publication date
Field of study
No full text
Crossref